Keio University

News

331-340 items (total 704)
Published on March 15, 2023

"1stRound," Japan's Largest Technology Seed Commercialization Program, Expands to 13 Co-sponsoring Universities and Renews Brand Design—Kyushu University, Keio University, Ritsumeikan University, Ritsumeikan Asia Pacific University, and Waseda University Join

Office of Communications and Public Relations

Published on March 14, 2023

"Co-creation Hub for a 'Symbiotic Upcycling Society' Connected by Respect" Selected as a Full-Scale Project in the Regional Co-creation Field of JST's Program on Open Innovation Platform for Industry-Academia Co-creation (COI-NEXT) - Launching with the Aim of Creating "Circular Creative Studies" through Interdisciplinary Fusion -

Office of Communications and Public Relations

Published on March 14, 2023

Which Patients Benefit from New Migraine Drugs (CGRP-related Monoclonal Antibodies)? - The First Paper from Japan -

Office of Communications and Public Relations

Published on March 14, 2023

Report on the Results of the First Nationwide Epidemiological Survey of MOG Antibody-Associated Disease, a Central Nervous System Autoimmune Disease—Aiming for Designation as an Intractable Disease and Development of Treatments

Office of Communications and Public Relations

Published on March 13, 2023

Newly Developed Bone Drill with Real Haptics Technology Capable of Transmitting Force and Tactile Feedback: A Major Step Forward in Realizing Safe Spinal Surgery

Office of Communications and Public Relations

Published on March 08, 2023

Keio University School of Medicine Holds 7th Keio Healthcare Venture Contest Finals

School of Medicine/Graduate School of Medicine

Published on March 07, 2023

Keio Colloquium 2023 Held

Office of Communications and Public Relations

Published on March 03, 2023

A New Perspective on Developmental Control by Ancient Viral "Fossils" in the Genome—Loss of Function of an Endogenized Virus Found to Impair Mouse Development

Office of Communications and Public Relations

Published on March 01, 2023

Elucidating the Genetic Characteristics and Pathogenesis of Hereditary Carotid Body Tumors in Japan: Exploring Clues for New Therapeutic Methods Through Analysis of Gene and Protein Expression

Office of Communications and Public Relations

Published on February 24, 2023

Development of a New Exercise Assessment Method for Patients with Cardiovascular Disease Using a Skin-Patch Biosensor for Sweat Lactate Measurement—Investigator-Initiated Trial Meets Primary Endpoint, Confirming Efficacy—

Office of Communications and Public Relations